FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / FASEB J / Autologous bone marrow mononuclear cells modulate joint home...
FASEB journal : official publication of the Federation of American Societies for Experimental Biology2019; 33(12); 14337-14353; doi: 10.1096/fj.201901684RR

Autologous bone marrow mononuclear cells modulate joint homeostasis in an equine in vivo model of synovitis.

Abstract: Osteoarthritis (OA) is characterized by macrophage-driven synovitis. Macrophages promote synovial health but become inflammatory when their regulatory functions are overwhelmed. Bone marrow mononuclear cells (BMNCs) are a rich source of macrophage progenitors used for treating chronic inflammation and produce essential molecules for cartilage metabolism. This study investigated the response to autologous BMNC injection in normal and inflamed joints. Synovitis was induced in both radiocarpal joints of 6 horses. After 8 h, 1 inflamed radiocarpal and 1 normal tarsocrural joint received BMNC injection. Contralateral joints were injected with saline. Synovial fluid was collected at 24, 96, and 144 h for cytology, cytokine quantification, and flow cytometry. At 144 h, horses were euthanatized, joints were evaluated, and synovium was harvested for histology and immunohistochemistry. Four days after BMNC treatment, inflamed joints had 24% higher macrophage counts with 10% more IL-10 cells than saline-treated controls. BMNC-treated joints showed gross and analytical improvements in synovial fluid and synovial membrane, with increasing regulatory macrophages and synovial fluid IL-10 concentrations compared with saline-treated controls. BMNC-treated joints were comparable to healthy joints histologically, which remained abnormal in saline-treated controls. Autologous BMNCs are readily available, regulate synovitis through macrophage-associated effects, and can benefit thousands of patients with OA.-Menarim, B. C., Gillis, K. H., Oliver, A., Mason, C., Ngo, Y., Werre, S. R., Barrett, S. H., Luo, X., Byron, C. R., Dahlgren, L. A. Autologous bone marrow mononuclear cells modulate joint homeostasis in an equine model of synovitis.
Get Full Text
Publication Date: 2019-10-30 PubMed ID: 31665925DOI: 10.1096/fj.201901684RRGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research investigates how autologous bone marrow mononuclear cells (BMNCs), a rich source of macrophage progenitors, can help in treating osteoarthritis by regulating synovitis. The study showed that the injection of BMNCs in both normal and inflamed joints of horses resulted in the improvement of synovial fluid and histological comparisons to healthy joints.

Research Objective

The main objective of this research was to examine the effects of bone marrow mononuclear cells (BMNCs) on synovitis – inflammation of the joint lining, often occurring in osteoarthritis (OA) patients. Specifically, the study aimed to investigate:

  • How autologous BMNC injection would affect normal and inflamed joints
  • The role of BMNCs in joint homeostasis regulation

Methodology

The study was conducted on six horses where synovitis was artificially induced in both their radiocarpal joints – equivalent to the human wrist. Post eight hours, one of the inflamed joints, along with a normal tarsocrural joint – equivalent to the human ankle, was injected with autologous BMNCs. For comparison, the remaining joints were injected with saline. Synovial fluid was collected at multiple time points for further analysis, which included cytology, cytokine quantification, and flow cytometry. Finally, the horses were euthanized to allow the joints to be evaluated in depth, with the synovium – a thin layer of tissue lining the joints/spaces that secrete synovial fluid – harvested for histology and immunohistochemistry.

Findings

The results showed that four days after BMNC treatment, the inflamed joints had a 24% higher macrophage count, with a 10% increase in interleukin-10 (IL-10) cells compared to the saline control group. The macrophages, derived from the injected BMNCs, were presumably helping to regulate the inflammation. BMNC-treated joints illustrated visible and analytical enhancements both in the synovial fluid and synovial membrane, with increased regulatory macrophages and increased synovial fluid IL-10 concentrations, compared to the saline-treated controls. Histologically, the BMNC-treated joints were similar to healthy joints, in contrast to the saline-treated joints, suggesting BMNCs can help restore joint health.

Conclusion

The study concludes that BMNCs, which are easily available, can potentially manage synovitis through effects related to macrophages. These findings are crucial in advancing potential treatment options for OA, a common and debilitating condition. The use of BMNCs has the potential to benefit thousands of patients afflicted with osteoarthritis.

Cite This Article

APA
Menarim BC, Gillis KH, Oliver A, Mason C, Ngo Y, Werre SR, Barrett SH, Luo X, Byron CR, Dahlgren LA. (2019). Autologous bone marrow mononuclear cells modulate joint homeostasis in an equine in vivo model of synovitis. FASEB J, 33(12), 14337-14353. https://doi.org/10.1096/fj.201901684RR

Publication

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
ISSN: 1530-6860
NlmUniqueID: 8804484
Country: United States
Language: English
Volume: 33
Issue: 12
Pages: 14337-14353

Researcher Affiliations

Menarim, Bruno C
  • Department of Large Animal Clinical Sciences, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA.
Gillis, Kiersten H
  • Department of Large Animal Clinical Sciences, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA.
Oliver, Andrea
  • Department of Large Animal Clinical Sciences, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA.
Mason, Caitlin
  • Department of Large Animal Clinical Sciences, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA.
Ngo, Ying
  • Department of Large Animal Clinical Sciences, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA.
Werre, Stephen R
  • Laboratory for Study Design and Statistical Analysis, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA.
Barrett, Sarah H
  • Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA.
Luo, Xin
  • Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA.
Byron, Christopher R
  • Department of Large Animal Clinical Sciences, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA.
Dahlgren, Linda A
  • Department of Large Animal Clinical Sciences, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA.

MeSH Terms

  • Animals
  • Bone Marrow Cells
  • Bone Marrow Transplantation
  • Female
  • Hematopoietic Stem Cell Transplantation / veterinary
  • Hematopoietic Stem Cells / physiology
  • Horse Diseases / therapy
  • Horses
  • Injections, Intra-Articular
  • Joints / metabolism
  • Joints / pathology
  • Leukocytes, Mononuclear
  • Male
  • Synovitis / therapy
  • Synovitis / veterinary

References

This article includes 137 references
  1. McIlwraith CW, Frisbie DD, Kawcak CE. The horse as a model of naturally occurring osteoarthritis. Bone Joint Res. 1, 297-309 (2012).
  2. Murphy LB, Cisternas MG, Pasta DJ, Helmick CG, Yelin EH. Medical expenditures and earnings losses among US adults with arthritis in 2013. Arthritis Care Res. (Hoboken) 70, 869-876 (2018).
  3. Sellam J, Berenbaum F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat. Rev. Rheumatol. 6, 625-635 (2010).
  4. Goldring MB, Otero M. Inflammation in osteoarthritis. Curr. Opin. Rheumatol. 23, 471-478 (2011).
  5. Mathiessen A, Conaghan PG. Synovitis in osteoarthritis: current understanding with therapeutic implications. Arthritis Res. Ther. 19, 18 (2017).
  6. Smith MD. The normal synovium. Open Rheumatol. J. 5, 100-106 (2011).
  7. Lopes EBP, Filiberti A, Husain SA, Humphrey MB. Immune contributions to osteoarthritis. Curr. Osteoporos. Rep. 15, 593-600 (2017).
  8. Bondeson J, Wainwright SD, Lauder S, Amos N, Hughes CE. The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis. Arthritis Res. Ther. 8, R187 (2006).
  9. Manferdini C, Paolella F, Gabusi E, Silvestri Y, Gambari L, Cattini L, Filardo G, Fleury-Cappellesso S, Lisignoli G. From osteoarthritic synovium to synovial-derived cells characterization: synovial macrophages are key effector cells. Arthritis Res. Ther. 18, 83 (2016).
  10. Pessler F, Chen LX, Dai L, Gomez-Vaquero C, Diaz-Torne C, Paessler ME, Scanzello C, Cakir N, Einhorn E, Schumacher HR. A histomorphometric analysis of synovial biopsies from individuals with Gulf War Veterans' Illness and joint pain compared to normal and osteoarthritis synovium. Clin. Rheumatol. 27, 1127-1134 (2008).
  11. Barrera P, Blom A, van Lent PL, van Bloois L, Beijnen JH, van Rooijen N, de Waal Malefijt MC, van de Putte LB, Storm G, van den Berg WB. Synovial macrophage depletion with clodronate-containing liposomes in rheumatoid arthritis. Arthritis Rheum. 43, 1951-1959 (2000).
  12. Blom AB, van Lent PL, Libregts S, Holthuysen AE, vander Kraan PM, van Rooijen N, van den Berg WB. Crucial role of macrophages in matrix metalloproteinase-mediated cartilage destruction during experimental osteoarthritis: involvement of matrix metalloproteinase 3. Arthritis Rheum. 56, 147-157 (2007).
  13. Van Lent PL, Blom AB, van der Kraan P, Holthuysen AE, Vitters E, van Rooijen N, Smeets RL, Nabbe KC, van den Berg WB. Crucial role of synovial lining macrophages in the promotion of transforming growth factor beta-mediated osteophyte formation. Arthritis Rheum. 50, 103-111 (2004).
  14. Bondeson J, Blom AB, Wainwright S, Hughes C, Caterson B, van den Berg WB. The role of synovial macrophages and macrophage-produced mediators in driving inflammatory and destructive responses in osteoarthritis. Arthritis Rheum. 62, 647-657 (2010).
  15. Kraus VB, McDaniel G, Huebner JL, Stabler TV, Pieper CF, Shipes SW, Petry NA, Low PS, Shen J, McNearney TA, Mitchell P. Direct in vivo evidence of activated macrophages in human osteoarthritis. Osteoarthritis Cartilage 24, 1613-1621 (2016).
  16. Van Weeren PR. General anatomy and physiology of joints. In Joint Disease in the Horse (McIlwraith, C. W., Frisbie, D. D., Kawcak, C. E., and van Weeren, P. R., eds.), Vol. 1, pp. 23-52, Elsevier, St Louis (2016).
  17. Fichadiya A, Bertram KL, Ren G, Yates RM, Krawetz RJ. Characterizing heterogeneity in the response of synovial mesenchymal progenitor cells to synovial macrophages in normal individuals and patients with osteoarthritis. J. Inflamm. (Lond.) 13, 12 (2016).
  18. Bellac CL, Dufour A, Krisinger MJ, Loonchanta A, Starr AE, Auf dem Keller U, Lange PF, Goebeler V, Kappelhoff R, Butler GS, Burtnick LD, Conway EM, Roberts CR, Overall CM. Macrophage matrix metalloproteinase-12 dampens inflammation and neutrophil influx in arthritis. Cell Rep. 9, 618-632 (2014).
  19. Culemann S, Grüneboom A, Nicolás-Ávila JA, Weidner D, Lämmle KF, Rothe T, Quintana JA, Kirchner P, Krljanac B, Eberhardt M, Ferrazzi F, Kretzschmar E, Schicht M, Fischer K, Gelse K, Faas M, Pfeifle R, Ackermann JA, Pachowsky M, Renner N, Simon D, Haseloff RF, Ekici AB, Bäuerle T, Blasig IE, Vera J, Voehringer D, Kleyer A, Paulsen F, Schett G, Hidalgo A, Krönke G. Locally renewing resident synovial macrophages provide a protective barrier for the joint. Nature 572, 670-675 (2019).
  20. Kennedy A, Fearon U, Veale DJ, Godson C. Macrophages in synovial inflammation. Front. Immunol. 2, 52 (2011).
  21. Scanzello CR, Goldring SR. The role of synovitis in osteoarthritis pathogenesis. Bone 51, 249-257 (2012).
  22. Rannou F. Pathophysiology of osteoarthritis. In Atlas of Osteoarthritis (Blanco FJ, Bruyère O, Cooper C, Guermazi A, Hayashi D, Hunter D, Javaid MK, Rannou F, Reginster JY, Roemer FW, eds.), pp. 37-41, Springer Healthcare Ltd, London (2018).
  23. Caron JP, Gandy JC, Brown JL, Sordillo LM. Omega-3 fatty acids and docosahexaenoic acid oxymetabolites modulate the inflammatory response of equine recombinant interleukin1β-stimulated equine synoviocytes. Prostaglandins Other Lipid Mediat. 142, 1-8 (2019).
  24. Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, Gordon S, Hamilton JA, Ivashkiv LB, Lawrence T, Locati M, Mantovani A, Martinez FO, Mege JL, Mosser DM, Natoli G, Saeij JP, Schultze JL, Shirey KA, Sica A, Suttles J, Udalova I, van Ginderachter JA, Vogel SN, Wynn TA. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41, 14-20 (2014).
  25. Olingy CE, San Emeterio CL, Ogle ME, Krieger JR, Bruce AC, Pfau DD, Jordan BT, Peirce SM, Botchwey EA. Non-classical monocytes are biased progenitors of wound healing macrophages during soft tissue injury. Sci. Rep. 7, 447 (2017).
  26. Dingenouts CKE, Goumans M-J, Bakker W. Mononuclear cells and vascular repair in HHT. Front. Genet. 6, 114 (2015).
  27. Godwin JW, Pinto AR, Rosenthal NA. Macrophages are required for adult salamander limb regeneration. Proc. Natl. Acad. Sci. USA 110, 9415-9420 (2013).
  28. Wynn TA, Barron L. Macrophages:master regulators of inflammation and fibrosis. Semin. Liver Dis. 30, 245-257 (2010).
  29. Fahy N, de Vries-van Melle ML, Lehmann J, Wei W, Grotenhuis N, Farrell E, van der Kraan PM, Murphy JM, Bastiaansen-Jenniskens YM, van Osch GJ. Human osteoarthritic synovium impacts chondrogenic differentiation of mesenchymal stem cells via macrophage polarisation state. Osteoarthritis Cartilage 22, 1167-1175 (2014).
  30. Jain S, Tran TH, Amiji M. Macrophage repolarization with targeted alginate nanoparticles containing IL-10 plasmid DNA for the treatment of experimental arthritis. Biomaterials 61, 162-177 (2015).
  31. Buckley CD, Gilroy DW, Serhan CN. Proresolving lipid mediators and mechanisms in the resolution of acute inflammation. Immunity 40, 315-327 (2014).
  32. Filardo G, Kon E, Roffi A, Di Matteo B, Merli ML, Marcacci M. Platelet-rich plasma: why intra-articular? A systematic review of preclinical studies and clinical evidence on PRP for joint degeneration. Knee Surg. Sports Traumatol. Arthrosc. 23, 2459-2474 (2015).
  33. Laudy AB, Bakker EW, Rekers M, Moen MH. Efficacy of platelet-rich plasma injections in osteoarthritis of the knee: a systematic review and meta-analysis. Br. J. Sports Med. 49, 657-672 (2015).
  34. Frisbie DD, Kawcak CE, Werpy NM, Park RD, McIlwraith CW. Clinical, biochemical, and histologic effects of intra-articular administration of autologous conditioned serum in horses with experimentally induced osteoarthritis. Am. J. Vet. Res. 68, 290-296 (2007).
  35. Lasarzik J, Bondzio A, Rettig M, Estrada R, Klaus C, Ehrle A, Einspanier R, Lischer CJ. Evaluation of two protocols using autologous conditioned serum for intra-articular therapy of equine osteoarthritis-a pilot study monitoring cytokines and cartilage-specific biomarkers. J. Equine Vet. Sci. 60, 35-42.e2 (2018).
  36. McIlwraith CW, Frisbie DD, Rodkey WG, Kisiday JD, Werpy NM, Kawcak CE, Steadman JR. Evaluation of intra-articular mesenchymal stem cells to augment healing of microfractured chondral defects. Arthroscopy 27, 1552-1561 (2011).
  37. Iijima H, Isho T, Kuroki H, Takahashi M, Aoyama T. Effectiveness of mesenchymal stem cells for treating patients with knee osteoarthritis: a meta-analysis toward the establishment of effective regenerative rehabilitation. NPJ Regen. Med. 3, 15 (2018).
  38. Souza M.V.d.. Osteoarthritis in horses-Part 2: a review of the intra-articular use of corticosteroids as a method of treatment. Braz. Arch. Biol. Technol. 59, 1-10 (2016).
  39. Barussi FC, Bastos FZ, Leite LM, Fragoso FY, Senegaglia AC, Brofman PR, Nishiyama A, Pimpão CT, Michelotto PV Jr. Intratracheal therapy with autologous bone marrow-derived mononuclear cells reduces airway inflammation in horses with recurrent airway obstruction. Respir. Physiol. Neurobiol. 232, 35-42 (2016).
  40. Cruz FF, Borg ZD, Goodwin M, Coffey AL, Wagner DE, Rocco PR, Weiss DJ. CD11b+ and Sca-1+ cells exert the main beneficial effects of systemically administered bone marrow-derived mononuclear cells in a murine model of mixed Th2/Th17 allergic airway inflammation. Stem Cells Transl. Med. 5, 488-499 (2016).
  41. Wang C, Yu X, Cao Q, Wang Y, Zheng G, Tan TK, Zhao H, Zhao Y, Wang Y, Harris D Ch. Characterization of murine macrophages from bone marrow, spleen and peritoneum. BMC Immunol. 14, 6 (2013).
  42. Behrendt P, Feldheim M, Preusse-Prange A, Weitkamp JT, Haake M, Eglin D, Rolauffs B, Fay J, Seekamp A, Grodzinsky AJ, Kurz B. Chondrogenic potential of IL-10 in mechanically injured cartilage and cellularized collagen ACI grafts. Osteoarthritis Cartilage 26, 264-275 (2018).
  43. Iannone F, De Bari C, Dell'Accio F, Covelli M, Cantatore FP, Patella V, Lo Bianco G, Lapadula G. Interleukin-10 and interleukin-10 receptor in human osteoarthritic and healthy chondrocytes. Clin. Exp. Rheumatol. 19, 139-145 (2001).
  44. Oh BJ, Jin SM, Choi JM, Oh SH, Shim W, Lee MS, Lee MK, Kim JH. Improved revascularization of islet grafts using an angiogenic monocyte subpopulation derived from spheroid culture of bone marrow mononuclear cells. Am. J. Transplant. 15, 1543-1554 (2015).
  45. Saw KY, Hussin P, Loke SC, Azam M, Chen HC, Tay YG, Low S, Wallin KL, Ragavanaidu K. Articular cartilage regeneration with autologous marrow aspirate and hyaluronic acid: an experimental study in a goat model. Arthroscopy 25, 1391-1400 (2009).
  46. Bekkers JE, Creemers LB, Tsuchida AI, van Rijen MH, Custers RJ, Dhert WJ, Saris DB. One-stage focal cartilage defect treatment with bone marrow mononuclear cells and chondrocytes leads to better macroscopic cartilage regeneration compared to microfracture in goats. Osteoarthritis Cartilage 21, 950-956 (2013).
  47. Agadi S, Shetty AK. Concise review: prospects of bone marrow mononuclear cells and mesenchymal stem cells for treating status epilepticus and chronic epilepsy. Stem Cells 33, 2093-2103 (2015).
  48. Cuende N, Rico L, Herrera C. Concise review: bone marrow mononuclear cells for the treatment of ischemic syndromes: medicinal product or cell transplantation?. Stem Cells Transl. Med. 1, 403-408 (2012).
  49. Nguyen TL, Nguyen HP, Nguyen TK. The effects of bone marrow mononuclear cell transplantation on the quality of life of children with cerebral palsy. Health Qual. Life Outcomes 16, 164 (2018).
  50. Goncars V, Kalnberzs K, Jakobsons E, Engele I, Briede I, Blums K, Erglis K, Erglis M, Patetko L, Muiznieks I, Erglis A. Treatment of knee osteoarthritis with bone marrow-derived mononuclear cell injection: 12-month follow-up. Cartilage 10, 26-35 (2019).
  51. Shizhu J, Xiangwei M, Xun S, Mingzi H, Bingrong L, Dexia K, Xinghong W, Fenghua P. Bone marrow mononuclear cell transplant therapy in mice with CCl4-induced acute liver failure. Turk. J. Gastroenterol. 23, 344-352 (2012).
  52. Corrêa-Letelier LF. Avances en el procesamiento de medula osea equina para el uso en terapia regenerativa. M. S. Thesis, Instituto de Ciencias Clinicas Veterinaria, Universidad Austral de Chile (2014).
  53. Ross TN, Kisiday JD, Hess T, McIlwraith CW. Evaluation of the inflammatory response in experimentally induced synovitis in the horse: a comparison of recombinant equine interleukin 1 beta and lipopolysaccharide. Osteoarthritis Cartilage 20, 1583-1590 (2012).
  54. De Grauw JC, van de Lest CH, van Weeren PR. Inflammatory mediators and cartilage biomarkers in synovial fluid after a single inflammatory insult: a longitudinal experimental study. Arthritis Res. Ther. 11, R35 (2009).
  55. Palmer JL, Bertone AL. Experimentally-induced synovitis as a model for acute synovitis in the horse. Equine Vet. J. 26, 492-495 (1994).
  56. Ludwig EK, Brandon Wiese R, Graham MR, Tyler AJ, Settlage JM, Werre SR, Petersson-Wolfe CS, Kanevsky-Mullarky I, Dahlgren LA. Serum and synovial fluid serum amyloid a response in equine models of synovitis and septic arthritis. Vet. Surg. 45, 859-867 (2016).
  57. Williams LB, Koenig JB, Black B, Gibson TW, Sharif S, Koch TG. Equine allogeneic umbilical cord blood derived mesenchymal stromal cells reduce synovial fluid nucleated cell count and induce mild self-limiting inflammation when evaluated in an lipopolysaccharide induced synovitis model. Equine Vet. J. 48, 619-625 (2016).
  58. Kamm JL, Nixon AJ, Witte TH. Cytokine and catabolic enzyme expression in synovium, synovial fluid and articular cartilage of naturally osteoarthritic equine carpi. Equine Vet. J. 42, 693-699 (2010).
  59. Jayadev C, Rout R, Price A, Hulley P, Mahoney D. Hyaluronidase treatment of synovial fluid to improve assay precision for biomarker research using multiplex immunoassay platforms. J. Immunol. Methods 386, 22-30 (2012).
  60. Zhang DE, Hetherington CJ, Gonzalez DA, Chen HM, Tenen DG. Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3. J. Immunol. 153, 3276-3284 (1994).
  61. Zamani F, Zare Shahneh F, Aghebati-Maleki L, Baradaran B. Induction of CD14 expression and differentiation to monocytes or mature macrophages in promyelocytic cell lines: new approach. Adv. Pharm. Bull. 3, 329-332 (2013).
  62. Safi W, Kuehnl A, Nüssler A, Eckstein HH, Pelisek J. Differentiation of human CD14+ monocytes: an experimental investigation of the optimal culture medium and evidence of a lack of differentiation along the endothelial line. Exp. Mol. Med. 48, e227 (2016).
  63. Fendl B, Weiss R, Eichhorn T, Spittler A, Fischer MB, Weber V. Storage of human whole blood, but not isolated monocytes, preserves the distribution of monocyte subsets. Biochem. Biophys. Res. Commun. 517, 709-714 (2019).
  64. Lévêque M, Simonin-Le Jeune K, Jouneau S, Moulis S, Desrues B, Belleguic C, Brinchault G, Le Trionnaire S, Gangneux JP, Dimanche-Boitrel MT, Martin-Chouly C. Soluble CD14 acts as a DAMP in human macrophages: origin and involvement in inflammatory cytokine/chemokine production. FASEB J. 31, 1891-1902 (2017).
  65. Xue J, Schmidt SV, Sander J, Draffehn A, Krebs W, Quester I, De Nardo D, Gohel TD, Emde M, Schmidleithner L, Ganesan H, Nino-Castro A, Mallmann MR, Labzin L, Theis H, Kraut M, Beyer M, Latz E, Freeman TC, Ulas T, Schultze JL. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity 40, 274-288 (2014).
  66. Zhou Y, Yoshida S, Kubo Y, Yoshimura T, Kobayashi Y, Nakama T, Yamaguchi M, Ishikawa K, Oshima Y, Ishibashi T. Different distributions of M1 and M2 macrophages in a mouse model of laser-induced choroidal neovascularization. Mol. Med. Rep. 15, 3949-3956 (2017).
  67. Odobasic D, Leech MT, Xue JR, Holdsworth SR. Distinct in vivo roles of CD80 and CD86 in the effector T-cell responses inducing antigen-induced arthritis. Immunology 124, 503-513 (2008).
  68. Finnegan A, Ashaye S, Hamel KM. B effector cells in rheumatoid arthritis and experimental arthritis. Autoimmunity 45, 353-363 (2012).
  69. Rivollier A, He J, Kole A, Valatas V, Kelsall BL. Inflammation switches the differentiation program of Ly6Chi monocytes from antiinflammatory macrophages to inflammatory dendritic cells in the colon. J. Exp. Med. 209, 139-155 (2012).
  70. Nawaz A, Aminuddin A, Kado T, Takikawa A, Yamamoto S, Tsuneyama K, Igarashi Y, Ikutani M, Nishida Y, Nagai Y, Takatsu K, Imura J, Sasahara M, Okazaki Y, Ueki K, Okamura T, Tokuyama K, Ando A, Matsumoto M, Mori H, Nakagawa T, Kobayashi N, Saeki K, Usui I, Fujisaka S, Tobe K. CD206+ M2-like macrophages regulate systemic glucose metabolism by inhibiting proliferation of adipocyte progenitors. Nat. Commun. 8, 286 (2017).
  71. Suzuki Y, Shirai M, Asada K, Yasui H, Karayama M, Hozumi H, Furuhashi K, Enomoto N, Fujisawa T, Nakamura Y, Inui N, Shirai T, Hayakawa H, Suda T. Macrophage mannose receptor, CD206, predict prognosis in patients with pulmonary tuberculosis. Sci. Rep. 8, 13129 (2018).
  72. Jablonski KA, Amici SA, Webb LM, Ruiz-Rosado JD, Popovich PG, Partida-Sanchez S, Guerau-de-Arellano M. Novel markers to delineate murine M1 and M2 macrophages. PLoS One 10, e0145342 (2015).
  73. Martinez FO, Gordon S, Locati M, Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 177, 7303-7311 (2006).
  74. Murray PJ. Macrophage polarization. Annu. Rev. Physiol. 79, 541-566 (2017).
  75. Behrendt P, Preusse-Prange A, Klüter T, Haake M, Rolauffs B, Grodzinsky AJ, Lippross S, Kurz B. IL-10 reduces apoptosis and extracellular matrix degradation after injurious compression of mature articular cartilage. Osteoarthritis Cartilage 24, 1981-1988 (2016).
  76. King A, Balaji S, Le LD, Crombleholme TM, Keswani SG. Regenerative wound healing: the role of interleukin-10. Adv. Wound Care (New Rochelle) 3, 315-323 (2014).
  77. Shapouri-Moghaddam A, Mohammadian S, Vazini H, Taghadosi M, Esmaeili SA, Mardani F, Seifi B, Mohammadi A, Afshari JT, Sahebkar A. Macrophage plasticity, polarization, and function in health and disease. J. Cell. Physiol. 233, 6425-6440 (2018).
  78. Rőszer T. Understanding the mysterious M2 macrophage through activation markers and effector mechanisms. Mediators Inflamm. 2015, 816460 (2015).
  79. Ibrahim S, Saunders K, Kydd JH, Lunn DP, Steinbach F. Screening of anti-human leukocyte monoclonal antibodies for reactivity with equine leukocytes. Vet. Immunol. Immunopathol. 119, 63-80 (2007).
  80. Ibrahim S, Steinbach F. Immunoprecipitation of equine CD molecules using anti-human MABs previously analyzed by flow cytometry and immunohistochemistry. Vet. Immunol. Immunopathol. 145, 7-13 (2012).
  81. Flaminio MJB F, Ibrahim S, Lunn DP, Stark R, Steinbach F. Further analysis of anti-human leukocyte mAbs with reactivity to equine leukocytes by two-colour flow cytometry and immunohistochemistry. Vet. Immunol. Immunopathol. 119, 92-99 (2007).
  82. Wagner B, Hillegas JM, Brinker DR, Horohov DW, Antczak DF. Characterization ofmonoclonal antibodies to equine interleukin-10 and detection of Tregulatory 1 cells in horses. Vet. Immunol. Immunopathol. 122, 57-64 (2008).
  83. Kabithe E, Hillegas J, Stokol T, Moore J, Wagner B. Monoclonal antibodies to equine CD14. Vet. Immunol. Immunopathol. 138, 149-153 (2010).
  84. McIlwraith CW, Frisbie DD, Kawcak CE, Fuller CJ, Hurtig M, Cruz A. The OARSI histopathology initiative -recommendations for histological assessments of osteoarthritis in the horse. Osteoarthritis Cartilage 18(Suppl 3), S93-S105 (2010).
  85. De Grauw JC, van de Lest CH, Brama PA, Rambags BP, van Weeren PR. In vivo effects of meloxicam on inflammatory mediators, MMP activity and cartilage biomarkers in equine joints with acute synovitis. Equine Vet. J. 41, 693-699 (2009).
  86. Van Loon JP, de Grauw JC, Brunott A, Weerts EA, van Weeren PR. Upregulation of articular synovial membrane m-opioid-like receptors in an acute equine synovitis model. Vet. J. 196, 40-46 (2013).
  87. Francoz D, Desrochers A, Latouche JS. Effect of repeated arthrocentesis and single joint lavage on cytologic evaluation of synovial fluid in 5 young calves. Can. J. Vet. Res. 71, 129-134 (2007).
  88. Giraldi-Guimarães A, de Freitas HT, Coelho BP, Macedo-Ramos H, Mendez-Otero R, Cavalcante LA, Baetas-da-Cruz W. Bone marrow mononuclear cells and mannose receptor expression in focal cortical ischemia. Brain Res. 1452, 173-184 (2012).
  89. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. M-1/M-2 macrophages and the Th1/Th2 paradigm. J. Immunol. 164, 6166-6173 (2000).
  90. Stables MJ, Shah S, Camon EB, Lovering RC, Newson J, Bystrom J, Farrow S, Gilroy DW. Transcriptomic analyses of murine resolution-phase macrophages. Blood 118, e192-e208 (2011).
  91. Trombetta AC, Soldano S, Contini P, Tomatis V, Ruaro B, Paolino S, Brizzolara R, Montagna P, Sulli A, Pizzorni C, Smith V, Cutolo M. A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement. Respir. Res. 19, 186 (2018).
  92. Cho DI, Kim MR, Jeong HY, Jeong HC, Jeong MH, Yoon SH, Kim YS, Ahn Y. Mesenchymal stem cells reciprocally regulate the M1/M2 balance in mouse bone marrow-derived macrophages. Exp. Mol. Med. 46, e70 (2014).
  93. Ryncarz RE, Anasetti C. Expression of CD86 on human marrow CD34(+) cells identifies immunocompetent committed precursors of macrophages and dendritic cells. Blood 91, 3892-3900 (1998).
  94. Amin AR, Islam AB. Genomic analysis and differential expression of HMG and S100A family in human arthritis: upregulated expression of chemokines, IL-8 and nitric oxide by HMGB1. DNA Cell Biol. 33, 550-565 (2014).
  95. Sergjenko A, Roelofs AJ, Riemen AHK, De Bari C. Bone marrow contribution to synovial hyperplasia following joint surface injury. Arthritis Res. Ther. 18, 166 (2016).
  96. Adair HS, Goble DO, Vanhooser S, Blackford JT, Rohrbach BW. Evaluation of use of dimethyl sulfoxide for intra-articular lavage in clinically normal horses. Am. J. Vet. Res. 52, 333-336 (1991).
  97. St Clair EW. Interleukin 10 treatment for rheumatoid arthritis. Ann. Rheum. Dis. 58 (Suppl 1) I99-I102 (1999).
  98. Said EA, Dupuy FP, Trautmann L, Zhang Y, Shi Y, El-Far M, Hill BJ, Noto A, Ancuta P, Peretz Y, Fonseca SG, Van Grevenynghe J, Boulassel MR, Bruneau J, Shoukry NH, Routy JP, Douek DC, Haddad EK, Sekaly RP. Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection. Nat. Med. 16, 452-459 (2010).
  99. Kasten KR, Muenzer JT, Caldwell CC. Neutrophils are significant producers of IL-10 during sepsis. Biochem. Biophys. Res. Commun. 393, 28-31 (2010).
  100. Riyazi N, Slagboom E, de Craen AJ, Meulenbelt I, Houwing-Duistermaat JJ, Kroon HM, van Schaardenburg D, Rosendaal FR, Breedveld FC, Huizinga TW, Kloppenburg M. Association of the risk of osteoarthritis with high innate production of interleukin-1beta and low innate production of interleukin-10 ex vivo, upon lipopolysaccharide stimulation. Arthritis Rheum. 52, 1443-1450 (2005).
  101. Ahrens N, Tormin A, Paulus M, Roosterman D, Salama A, Krenn V, Neumann U, Scheding S. Mesenchymal stem cell content of human vertebral bone marrow. Transplantation 78, 925-929 (2004).
  102. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147 (1999).
  103. Bogers SH. Turning round: optimizing the anti-inflammatory properties of equine bone marrow derived mesenchymal stem cells for osteoarthritis through three-dimensional culture. Ph. D. thesis, Virginia Polythecnic Institute and State University (2017).
  104. Manferdini C, Maumus M, Gabusi E, Piacentini A, Filardo G, Peyrafitte JA, Jorgensen C, Bourin P, Fleury-Cappellesso S, Facchini A, Noël D, Lisignoli G. Adipose-derived mesenchymal stem cells exert antiinflammatory effects on chondrocytes and synoviocytes from osteoarthritis patients through prostaglandin E2. Arthritis Rheum. 65, 1271-1281 (2013).
  105. Manferdini C, Paolella F, Gabusi E, Gambari L, Piacentini A, Filardo G, Fleury-Cappellesso S, Barbero A, Murphy M, Lisignoli G. Adipose stromal cells mediated switching of the pro-inflammatory profile of M1-like macrophages is facilitated by PGE2: in vitro evaluation. Osteoarthritis Cartilage 25, 1161-1171 (2017).
  106. Pietras EM, Mirantes-Barbeito C, Fong S, Loeffler D, Kovtonyuk LV, Zhang S, Lakshminarasimhan R, Chin CP, Techner JM, Will B, Nerlov C, Steidl U, Manz MG, Schroeder T, Passegué E. Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal. Nat. Cell Biol. 18, 607-618 (2016).
  107. Frisbie DD, Al-Sobayil F, Billinghurst RC, Kawcak CE, McIlwraith CW. Changes in synovial fluid and serum biomarkers with exercise and early osteoarthritis in horses. Osteoarthritis Cartilage 16, 1196-1204 (2008).
  108. Park JY, Pillinger MH, Abramson SB. Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases. Clin. Immunol. 119, 229-240 (2006).
  109. Bertone AL, Palmer JL, Jones J. Synovial fluid cytokines and eicosanoids as markers of joint disease in horses. Vet. Surg. 30, 528-538 (2001).
  110. Serhan CN, Petasis NA. Resolvins and protectins in inflammation resolution. Chem. Rev. 111, 5922-5943 (2011).
  111. Poulsen RC, Gotlinger KH, Serhan CN, Kruger MC. Identification of inflammatory and proresolving lipid mediators in bone marrow and their lipidomic profiles with ovariectomy and omega-3 intake. Am. J. Hematol. 83, 437-445 (2008).
  112. Tsubosaka Y, Maehara T, Imai D, Nakamura T, Kobayashi K, Nagata N, Fujii W, Murata T. Hematopoietic prostaglandin D synthase-derived prostaglandin D2 ameliorates adjuvant-induced joint inflammation in mice. FAASEB J. 33, 6829-6837 (2019).
  113. Xu Q, Sun XC, Shang XP, Jiang HS. Association of CXCL12 levels in synovial fluid with the radiographic severity of knee osteoarthritis. J. Invest. Med. 60, 898-901 (2012).
  114. Dymock DC, Brown MP, Merritt KA, Trumble TN. Concentrations of stromal cell-derived factor-1 in serum, plasma, and synovial fluid of horses with osteochondral injury. Am. J. Vet. Res. 75, 722-730 (2014).
  115. Scanzello CR. Chemokines and inflammation in osteoarthritis: insights from patients and animal models. J. Orthop. Res. 35, 735-739 (2017).
  116. Morris EA, Treadwell BV. Effect of interleukin 1 on articular cartilage from young and aged horses and comparison with metabolism of osteoarthritic cartilage. Am. J. Vet. Res. 55, 138-146 (1994).
  117. Caron JP, Fernandes JC, Martel-Pelletier J, Tardif G, Mineau F, Geng C, Pelletier JP. Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis. Suppression of collagenase-1 expression. Arthritis Rheum. 39, 1535-1544 (1996).
  118. Pelletier JP, Caron JP, Evans C, Robbins PD, Georgescu HI, Jovanovic D, Fernandes JC, Martel-Pelletier J. In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy. Arthritis Rheum. 40, 1012-1019 (1997).
  119. Todhunter PG, Kincaid SA, Todhunter RJ, Kammermann JR, Johnstone B, Baird AN, Hanson RR, Wright JM, Lin HC, Purohit RC. Immunohistochemical analysis of an equine model of synovitis-induced arthritis. Am. J. Vet. Res. 57, 1080-1093 (1996).
  120. Yaron I, Meyer FA, Dayer JM, Bleiberg I, Yaron M. Some recombinant human cytokines stimulate glycosaminoglycan synthesis in human synovial fibroblast cultures and inhibit it in human articular cartilage cultures. Arthritis Rheum. 32, 173-180 (1989).
  121. Goldring MB, Birkhead J, Sandell LJ, Krane SM. Synergistic regulation of collagen gene expression in human chondrocytes by tumor necrosis Factor-α and interleukin-1βa. Ann. N. Y. Acad. Sci. 580, 536-539 (1990).
  122. Lettesjö H, Nordström E, Ström H, Nilsson B, Glinghammar B, Dahlstedt L, Möller E. Synovial fluid cytokines in patients with rheumatoid arthritis or other arthritic lesions. Scand. J. Immunol. 48, 286-292 (1998).
  123. Peffers MJ, McDermott B, Clegg PD, Riggs CM. Comprehensive protein profiling of synovial fluid in osteoarthritis following protein equalization. Osteoarthritis Cartilage 23, 1204-1213 (2015).
  124. Li J, Liu CH, Xu DL, Gao B. Clinicopathological significance of CD206-positive macrophages in patients with acute tubulointerstitial disease. Int. J. Clin. Exp. Pathol. 8, 11386-11392 (2015).
  125. Firth EC, Wensing T, Seuren F. An induced synovitis disease model in ponies. Cornell Vet. 77, 107-118 (1987).
  126. Smith G, Bertone AL, Kaeding C, Simmons EJ, Apostoles S. Anti-inflammatory effects of topically applied dimethyl sulfoxide gel on endotoxin-induced synovitis in horses. Am. J. Vet. Res. 59, 1149-1152 (1998).
  127. De Grauw JC, Visser-Meijer MC, Lashley F, Meeus P, van Weeren PR. Intra-articular treatment with triamcinolone compared with triamcinolone with hyaluronate: a randomised open-label multicentre clinical trial in 80 lame horses. Equine Vet. J. 48, 152-158 (2016).
  128. Van Loon JP, de Grauw JC, van Dierendonck M, L'ami JJ, Back W, van Weeren PR. Intra-articular opioid analgesia is effective in reducing pain and inflammation in an equine LPS induced synovitis model. Equine Vet. J. 42, 412-419 (2010).
  129. Kay AT, Bolt DM, Ishihara A, Rajala-Schultz PJ, Bertone AL. Anti-inflammatory and analgesic effects of intra-articular injection of triamcinolone acetonide, mepivacaine hydrochloride, or both on lipopolysaccharide-induced lameness in horses. Am. J. Vet. Res. 69, 1646-1654 (2008).
  130. Morton AJ, Campbell NB, Gayle JM, Redding WR, Blikslager AT. Preferential and non-selective cyclooxygenase inhibitors reduce inflammation during lipopolysaccharide-induced synovitis. Res. Vet. Sci. 78, 189-192 (2005).
  131. Verde CR, Simpson MI, Frigoli A, Landoni MF. Enantiospecific pharmacokinetics of ketoprofen in plasma and synovial fluid of horses with acute synovitis. J. Vet. Pharmacol. Ther. 24, 179-185 (2001).
  132. McIlwraith CW, Fessler JF, Blevins WE, Page EH, Rebar AH, Van Sickle DC, Coppoc GL. Experimentally induced arthritis of the equine carpus: clinical determinations. Am. J. Vet. Res. 40, 11-20 (1979).
  133. McIlwraith CW, Van Sickle DC. Experimentally induced arthritis of the equine carpus: histologic and histochemical changes in the articular cartilage. Am. J. Vet. Res. 42, 209-217 (1981).
  134. Van de Water E, Oosterlinck M, Dumoulin M, Korthagen NM, van Weeren PR, van den Broek J, Everts H, Pille F, van Doorn DA. The preventive effects of two nutraceuticals on experimentally induced acute synovitis. Equine Vet. J. 49, 532-538 (2017).
  135. Rose BJ, Kooyman DL. Atale of two joints: the role of matrix metalloproteases in cartilage biology. Dis. Markers 2016, 4895050 (2016).
  136. Karagianni AE, Kapetanovic R, Summers KM, McGorum BC, Hume DA, Pirie RS. Comparative transcriptome analysis of equine alveolar macrophages. Equine Vet. J. 49, 375-382 (2017).
  137. Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, Richards DR, McDonald-Smith GP, Gao H, Hennessy L, Finnerty CC, López CM, Honari S, Moore EE, Minei JP, Cuschieri J, Bankey PE, Johnson JL, Sperry J, Nathens AB, Billiar TR, West MA, Jeschke MG, Klein MB, Gamelli RL, Gibran NS, Brownstein BH, Miller-Graziano C, Calvano SE, Mason PH, Cobb JP, Rahme LG, Lowry SF, Maier RV, Moldawer LL, Herndon DN, Davis RW, Xiao W, Tompkins RG. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci USA 110, 3507-3512 (2013).

Citations

This article has been cited 12 times.
  1. Bowlby CM, Purmessur D, Durgam SS. Equine peripheral blood CD14(+) monocyte-derived macrophage in-vitro characteristics after GM-CSF pretreatment and LPS+IFN-γ or IL-4+IL-10 differentiation. Vet Immunol Immunopathol 2023 Jan;255:110534.
    doi: 10.1016/j.vetimm.2022.110534pubmed: 36502640google scholar: lookup
  2. Song Y, Wu Z, Zhao P. The Function of Metformin in Aging-Related Musculoskeletal Disorders. Front Pharmacol 2022;13:865524.
    doi: 10.3389/fphar.2022.865524pubmed: 35392559google scholar: lookup
  3. Menarim BC, El-Sheikh Ali H, Loux SC, Scoggin KE, Kalbfleisch TS, MacLeod JN, Dahlgren LA. Transcriptional and Histochemical Signatures of Bone Marrow Mononuclear Cell-Mediated Resolution of Synovitis. Front Immunol 2021;12:734322.
    doi: 10.3389/fimmu.2021.734322pubmed: 34956173google scholar: lookup
  4. Estrada McDermott J, Pezzanite L, Goodrich L, Santangelo K, Chow L, Dow S, Wheat W. Role of Innate Immunity in Initiation and Progression of Osteoarthritis, with Emphasis on Horses. Animals (Basel) 2021 Nov 13;11(11).
    doi: 10.3390/ani11113247pubmed: 34827979google scholar: lookup
  5. Woźniczka M, Błaszczak-Świątkiewicz K. New Generation of Meso and Antiprogestins (SPRMs) into the Osteoporosis Approach. Molecules 2021 Oct 27;26(21).
    doi: 10.3390/molecules26216491pubmed: 34770897google scholar: lookup
  6. Menarim BC, MacLeod JN, Dahlgren LA. Bone marrow mononuclear cells for joint therapy: The role of macrophages in inflammation resolution and tissue repair. World J Stem Cells 2021 Jul 26;13(7):825-840.
    doi: 10.4252/wjsc.v13.i7.825pubmed: 34367479google scholar: lookup
  7. Ribitsch I, Oreff GL, Jenner F. Regenerative Medicine for Equine Musculoskeletal Diseases. Animals (Basel) 2021 Jan 19;11(1).
    doi: 10.3390/ani11010234pubmed: 33477808google scholar: lookup
  8. Menarim BC, Gillis KH, Oliver A, Ngo Y, Werre SR, Barrett SH, Rodgerson DH, Dahlgren LA. Macrophage Activation in the Synovium of Healthy and Osteoarthritic Equine Joints. Front Vet Sci 2020;7:568756.
    doi: 10.3389/fvets.2020.568756pubmed: 33324696google scholar: lookup
  9. Chaimbeul SF, Rodrigues NNP, Thurston DD, Scoggin KE, Janes J, Jacobs CA, MacLeod JN, Stone AV, Menarim BC. PPARγ Agonism Modulates Synovial Macrophage and Cartilage Responses in an Equine Model of Synovial Inflammation-Implications for Joint Therapy. Biomolecules 2025 Sep 1;15(9).
    doi: 10.3390/biom15091267pubmed: 41008574google scholar: lookup
  10. Dörner C, Lagos N, Oyaneder L, Menarim BC, Ramírez-Toloza G. Synovial Fluid Biomarker Profile After Intra-Articular Administration of Neosaxitoxin in Horses: A Feasibility Study. Animals (Basel) 2025 Aug 21;15(16).
    doi: 10.3390/ani15162453pubmed: 40867781google scholar: lookup
  11. Ammons DT, Chow L, Goodrich L, Bass L, Larson B, Williams ZJ, Stoneback JW, Dow S, Pezzanite LM. Characterization of the single cell landscape in normal and osteoarthritic equine joints. Ann Transl Med 2024 Oct 20;12(5):88.
    doi: 10.21037/atm-24-40pubmed: 39507442google scholar: lookup
  12. Everett JB, Menarim BC, Barrett SH, Bogers SH, Byron CR, Pleasant RS, Werre SR, Dahlgren LA. Intra-articular bone marrow mononuclear cell therapy improves lameness from naturally occurring equine osteoarthritis. Front Vet Sci 2023;10:1256284.
    doi: 10.3389/fvets.2023.1256284pubmed: 37876630google scholar: lookup
Subscribe to our newsletter
Join 99,357 horse owners like you who receive our email updates on horse health and nutrition.